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Our aim of this study was to compare the accuracy of three different modalities for testing sensory
neuropathy in diabetic patients with and without diabetic foot problems. The three devices used included the
pin-prick testing using the Neurotip† (PPT), the SemmesWeinstein 5.07/10 g monofilament testing
(SWMT), and the rapid-current perception threshold (R-CPT) measurements using the Neurometer†
testing. Our study population consisted of 54 patients (108 feet) with diabetic foot problems treated at the
National University Hospital in Singapore by our multi-disciplinary diabetic foot care team. Our results
showed no difference in sensory neuropathy detected by PPT and 5.07/10 g SWMT in both the pathological
and normal foot. In the pathological foot, there was significant increase in sensory neuropathy detected by
the Neurometer† device at both the big toe and ankle sites as compared to PPTand 5.07/10 g SWMT. In the
normal foot, there was a significant increase in sensory neuropathy detected by the Neurometer† device at the
big toe site only as compared to PPTand 5.07/10 g SWMT. Finally, the Neurometer† measurements detected
a statistically higher proportion of feet with sensory neuropathy as compared to detection by the PPTor 5.07/
10 g SWMT.
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D
iabetic sensory neuropathy is a common compli-
cation of diabetes mellitus (1). The exact cause of
diabetic neuropathy is not well understood. A
combination of metabolic and vascular factors is postu-
lated to be involved (24). Peripheral neuropathy is
associated with an increased risk of developing a foot
ulceration, gangrenous changes, and/or lower extremity
amputations (46). A recent systematic review of various
risk stratification systems has also confirmed that diabetic
neuropathy is one of the main risk factors for develop-
ment of diabetic foot ulcers (7). Diabetic foot ulcers
related to diabetic neuropathy constitutes one of the main
leading causes for diabetic foot infections (8). Diabetic
neuropathy has also been associated as a predictive factor
for limb loss (below knee and above knee amputations) in
diabetic foot patients (9). In view of the aforementioned
potential complications, it is evident that diabetic neuro-
pathy is significantly associated with a patient’s increased
rate of morbidity and mortality (10). Due to these
reasons, it is important to detect peripheral neuropathy
early in the diabetic patient so that diabetic foot care
education can be provided and protective measures can be
used to avoid devastating complications with the diabetic
foot. Our aim of this article was to clinically compare the
accuracy of three different modalities for testing sensory
neuropathy in the diabetic and non-diabetic population.
Our tests included the pin-prick testing (PPT); Semmes
Weinstein 5.07/10 g monofilament testing (SWMT), and
the rapid-current perception threshold (R-CPT) measure-
ments using the Neurometer†.
Materials and methods
Our study population consisted of 54 patients with
diabetes mellitus and associated diabetic foot complica-
tions treated by our multi-disciplinary team at the
National University Hospital in Singapore from January
to June 2005. All except one patient had type 2 diabetes
mellitus. The types of diabetic foot problems (DFP)
were classified according to the King’s classification
(11). All data were documented using a study protocol
including age, sex, race, type and duration of diabetes
mellitus, presence of co-morbidities, laboratory values
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tion rate, C-reactive protein, white blood cell count, blood
urea nitrogen and creatinine levels, blood cultures, and
soft tissue culture and sensitivities.
Pin prick testing
A disposable, sterile calibrated 10g Neurotip† (Owen
Mumford, UK) was used for the PPT (single use only for
each patient) (Fig. 1a). A constant force was applied
perpendicularlyon the skin of the foot until the calibrated
mark was reached (Fig. 1b). A record was made as to
whether the patient responded to any sensation felt in the
foot. This was compared to the sensation felt on the
dorsum of the hand on the same side. The area of sensory
disturbance was also mapped out for both feet.
SemmesWeinstein 5.07/10 g monofilament testing
The SemmesWeinstein 5.07/10 g monofilament was used
and pressed against the skin perpendicularly until the
monofilament buckled (12). This applied a consistent
10 g force to the site. The test was performed on 10 test
sites  nine on the plantar surface of the foot and one on
the dorsum of the foot (6). The nine plantar sites were
the pulps of the first, third, and fifth toes, over the skin
overlying the first, third, and fifth metatarsal heads,
two in the arch of the foot and the heel (Fig. 2). The
dorsal site was in the first web space. Patients who could
feel 7 or more out of 10 sites were categorized as normal
while patients with B7 test sites felt were classified as
having loss of protective sensation. The authors in this
study selected this 10 point 5.07/10 SWMT as the
standard for diagnosing neuropathy in this study.
Neurometer† testing
The Neurometer† (Neurotron, Baltimore, Maryland,
USA) testing generated rapid current perception thresh-
old (R-CPT) readings based on the minimal strength of
alternating current stimulus that the patient could detect.
The test was double-blinded and the two test sites that
were used in our study included the big toe and the ankle
(Fig. 3). The Neurometer† applied three different fre-
quencies (2000, 250, and 5 Hz) of alternating current
signals at levels calibrated between 0 and 10 mA. Each
frequency stimulated a different group of nerve fibers;
2000 Hz stimulated alpha beta fibers, 250 Hz stimulated
alpha delta fibers (both fibers being large diameter
fibers), while 5 Hz stimulated small diameter C fibers.
At each frequency, the current was increased over a
variable time interval until the patient could detect a
sensation at the test site. This was repeated until three
concurrent values for current intensity were obtained.
A R-CPT value was then generated for each frequency.
The R-CPT values obtained for each frequency at each
test site ranged from 1 to 25; 6 to 13 being normal,
1 to 5 indicating hyperesthesia, and 14 to 25 indicating
hypoesthesia. Both hyperesthesia and hypoesthesia indi-
cated the presence of sensory neuropathy. The extent of
neuropathy present using the two test sites were also
documented for both feet.
Statistical analysis was employed using the chi-square
test to compare the results obtained using the three
different methods. A p-value of B0.05 represented a
significantdifferencewhileap-valueof B0.001washighly
statistically significant.
Results
Our study population ranged between 30 and 80 years
old, the average being 56.7 years old. The ratio of males
to females was 1:1 and our demographic distribution
was 42.6% Chinese, 33.3% Malays, 20.4% Indians, and
3.7% of other races. The majority of our patients had
been diagnosed with diabetes mellitus for more than
10 years; 38 out of 54 patients (70.4%). In our study
cohort of 54 patients (108 feet), there were 61 feet with
DFP and 47 with normal feet. Seven patients had
bilateral DFP. The most common DFP that was encoun-
tered included 21 diabetic foot ulcers, 10 abscesses, 8 with
cellulitis, and 6 with gangrene. In other pathological
feet, the complications were combinations of an ulcer
and abscess in 6 feet, ulcer and gangrene in 6 feet, and
abscess with gangrene in 4 feet.
Fig. 4 shows the results of PPT, 5.07/10 g SWMT,
and R-CPT testing in the pathological foot. There was
no significant difference in sensory neuropathy detected
by PPT compared to neuropathy detected by SWMT
(p0.93). There was a statistically significant increase in
sensory neuropathy detected by Neurometer† testing at
the big toe site for all three frequencies as compared
(a) (b)
Fig. 1. (a) Showing the Neurotip† as part of the Neuropen†.
(b) Showing the Neurotip† being used on the foot.
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0.0004). There was also a statistically significant increase
in sensory neuropathy detected by Neurometer† testing
at the ankle site for all three frequencies as compared
to PPT (2000 Hz: p0.0002, 250 Hz: p0.029, 5 Hz:
p0.013). When the R-CPT readings were compared
with the results of SWMT, there was a significant increase
in sensory neuropathy detected by Neurometer† testing
at the big toe site for all three frequencies as compared
to SWMT (2000 Hz: p0.016, 250 Hz: p0.007, 5 Hz:
p0.0005). There was also found a significant increase in
sensory neuropathy detected by Neurometer† testing
at the ankle site for all three frequencies as compared
to SWMT (2000 Hz: p0.0003, 250 Hz: p0.032, 5 Hz:
p0.015).
Fig. 5 shows the results of PPT, 5.07/10 g SWMT,
and R-CPT testing in the normal foot. There was
no significant difference in sensory neuropathy detected
by PPT compared to neuropathy detected by SWMT
(p0.80). There was a statistically significant increase
in sensory neuropathy detected by Neurometer† testing
at the big toe site for all three frequencies as compared
to PPT (2000 Hz: p0.007, 250 Hz: p0.001, 5 Hz:
p0.001. However, there was no significant increase in
sensory neuropathy detected by Neurometer† testing at
the ankle site for all three frequencies as compared
Dorsum  Plantar 
Fig. 2. Showing the 10 sites in the foot for 5.07 SemmesWeinstein monoﬁlament testing (SWMT).
(c)  (b) 
(a) 
Fig. 3. (a) Showing the Neurometer† Machine. (b) Electrodes applied to the big toe site. (c) Electrodes applied to the ankle site.
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p0.52). When the Neurometer† readings were com-
pared with the results of 5.07/10 g SWMT, we found
a significant increase in sensory neuropathy detected
by Neurometer† testing at the big toe site for all three
frequencies as compared to SWMT (2000 Hz: p0.017,
250 Hz: p0.004, 5 Hz: p0.003). However, there was
no significant increase in sensory neuropathy detected
by Neurometer† testing at the ankle site for all three
frequencies as compared to SWMT (2000 Hz: p0.20,
250 Hz: p0.74, 5 Hz: p0.81).
Discussion
The 5.07/10 g SWMT has been widely preferred as a
screening tool for detection of peripheral diabetic neuro-
pathy in view of its cost, portability, ease of administra-
tion, and higher acceptance by patients (13). In this
study, we have compared PPT and R-CPT with the
5.07/10 g SWMT. Our study demonstrated no signifi-
cant difference between neuropathy detected by PPT
compared to neuropathy detected by 5.07/10 g SWMT.
We found high sensitivity of the R-CPT test in compari-
son with the SWMT and PPT. However, it must be noted
that R-CPT had not been validated for diagnosing
diabetic neuropathy in this study.
The Neurotip† has been described by Paisley et al.
to be a sensitive and inexpensive device for assessing
nerve function, especially when combined with the 10 g
monofilament test in the Neuropen† (14). The single use
and sterile neurological examination pins provide an
advantage in terms preventing any cross-contamination
of infections from one patient to another.
The Neurometer† has been described as a useful
tool for detection of sensory neuropathy (15, 16). It is
interesting to note that in a study by Cheng et al. in 1999
assessing peripheral neuropathy by 5.07/10 g SWMT, 128
Hz graduated tuning fork testing, and Neurometer†
testing in 558 Type II diabetics, 59 were found to be
positive on 5.07/10 g SWMT, 45 positive on Vibration
Perception Threshold, and 189 positive on Neurometer†
measurements (17). In this study, Cheng et al. (17) found
that the Neurometer† detected neuropathy in more
patients as compared to 5.07/10 g SWMT and Vibration
Perception Threshold (the differences being found to be
statistically significant).
Lastly, there has been a great variation in both the
reference test and methodology when using the 5.07/10
SWMT (18). A recent systematic review of the accuracy
of 5.07/10 SWMT revealed a sensitivity ranging from 57
to 93% and specificity from 75 to 100% with a three-site
test being the ideal methodology to maximize the diag-
nostic value (18). A limitation of our study would be that
we used the 10-site test for our investigations using
the 5.07/10 SWMT, which may have under diagnosed
patients with peripheral neuropathy.
Conclusion
Comparison of the three different modalities of testing in
this study showed that there was no difference between
neuropathy detected by PPT compared to neuropathy
detected by 5.07/10 g SWMT. However, Neurometer†
measurements detected a statistically higher proportion
of feet with sensory neuropathy compared to detection by
PPT or by 5.07/10 g SWMT.
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